Northwestern University
· Bladder cancer is the fourth-most diagnosed cancer in men, and survival for patients with advanced bladder is less than a year
· Doctors don't know which bladder cancer patients will benefit from immunotherapy
·Treatment of patients with ineffective therapy causes unneeded harm and delays treatment with optimal therapies
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
